[Hepatitis C following administration of intravenous immunoglobulins].
Five patients with hepatitis C virus infection of different severity and evolution following the administration of intravenous (i.v.) immunoglobulins (Igs) are presented. The important morbidity of hepatitis C virus infection and the need for adequate donor screening are discussed, as is accurate indication of these drugs in the management of patients with immunosuppression and other diseases.
Cabrera Chaves
T
T
Servicio de Aparato Digeso, Hospital Miguel Servet, Zaragoza.
Simón Marco
M A
MA
Gomollón García
F
F
Botella Esteban
M T
MT
Uribarrena Echebarría
R
R
D000293:Adolescent; D000328:Adult; D001782:Blood Donors; D003937:Diagnosis, Differential; D005260:Female; D006526:Hepatitis C / Q000175:diagnosis / Q000635:transmission*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
D016756:Immunoglobulins, Intravenous
Hepatitis C tras administración de inmunoglobulinas intravenosas.